China Nuokang Bio-Pharmaceutical (NKBP) Reports Q3 Earnings of $0.06
Tweet
Share
E-mailGet Alerts NKBP Hot Sheet
Join SI Premium – FREE
China Nuokang Bio-Pharmaceutical, Inc. (NASDAQ: NKBP) reported Q3 EPS of $0.06. Revenue for the quarter increased 3.5% to $13.7 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meritage Homes Corporation (MTH) Tops Q1 EPS by 151c; offers guidance
- Oceaneering (OII) Tops Q1 EPS by 5c, confirms prior guidance
- Universal Health Realty (UHT) Reports Q1 EPS of $0.38
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
